resTORbio Reports Second Quarter 2019 Financial Results and Corporate Update

NEXT STORY
Gritstone Oncology Announces First Patient Dosed with SLATE, its “Off-The-Shelf” Neoantigen Immunotherapy
PREV STORY
Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunovaccine Announces Financial Results for Quarter Ended June 30, 2017

HALIFAX, Nova Scotia, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

author_avatar
NASDAQ Market News

Celsion Announces Publication of the Study of ThermoDox® + Ultrasound, “TARDOX Study Protocol” in the Journal of Therapeutic Ultrasound

Collaboration with University of Oxford to Execute a Clinical Trial Using Focused Ultrasound and ...

author_avatar
NASDAQ Market News

Nemucore Medical Innovations to Present at Needham & Company’s 15th Annual Healthcare Conference

WORCESTER, Mass., April 05, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately ...

author_avatar
NASDAQ Market News